| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |